期刊文献+

国内外含可待因和羟考酮复方制剂说明书的比较 被引量:1

Comparison of the Drug Package Inserts of Domestic and Foreign Compound Preparations Containing Narcotic Drugs
下载PDF
导出
摘要 目的规范国内含麻醉药品复方制剂说明书,指导安全合理用药。方法从安全用药的角度,如药物滥用与依赖、禁忌、注意事项等方面,对国内外的说明书进行比较。结果国内该类制剂说明书中警示信息不足;国内和国外说明书大多禁忌描述不全;中、英文说明书不对应。结论可以参照麻醉药品单方制剂和国外含麻醉药品复方制剂的说明书来修订国内的该类制剂说明书。 Objective To regulate the drug package inserts of domestic compound preparations containing narcotic drugs and improve rational use of these drugs. Methods From the safe medication's angle, choose drug abuse and dependence, contraindications, precautions and so on from the drug package inserts, and then contrastively analyse the domestic and foreign part. Results The domestic drug package inserts are lack of warnings. Both the domestic and the foreign ones are not all-inclusive about contraindications. The Chinese and English drug package inserts do not correspond. Conclusion We can reference package inserts of the narcotic drugs unilaterally preparations and foreign compound preparations containing narcotic drugs to revise domestic ones.
出处 《中国药物警戒》 2011年第10期603-605,共3页 Chinese Journal of Pharmacovigilance
关键词 麻醉药品 复方制剂 说明书 警示 narcotic drugs compound preparations drug package inserts warnings
  • 相关文献

参考文献6

  • 1国家食品药品监督管理局.关于含麻醉药品复方制剂管理的通知[EB/OL].2004-03—19[2011—01—23].http://www.sfda.gov.cn/WS01/CL0055/10285.html.
  • 2mallinckrodt Inc.Oxycodone and acetaminophen Tablets [EB/OL]. [2011-1-23]. http://pharmaceuticals, mallinckrodt, corn/products/ Product.asp?UT=0&ProductlD=5412.
  • 3Ortho-Mcneil-JanssenPharmaceuticalsInc..Tylox.[EB/OL]. [2011-01-23].http://www.or tho-mcneil.com/or tho-mcneil/products__list.html.
  • 4Ortho-Mcneil-Janssen Pharmaceuticals Inc.Tylenol with codeine [EB/OL]. [2011-1-23].http://www.ortho-mcnei1.com/ortho-mcneil/ products_list.html.
  • 5董圣惠(译),刘萍(校).对乙酰氨基酚:一个必须紧急加强管理的药物[J].中国药物应用与监测,2007,4(4):56-58. 被引量:3
  • 6赵映,方渡,陈林明,陈绍俊.对乙酰氨基酚的肝毒性研究进展[J].中国现代药物应用,2008,2(15):114-115. 被引量:22

二级参考文献7

  • 1[2]Bernhard H,Lauterbury 1Early disturbance1 of calcium translocation across the plasma1 membrane in toxic liver injuny J.Hepa tology,1987,7:1179-1184.
  • 2[3]Forrest JA,Clements JA,Prescott LF.Clinical pharmacokinetics of paracetamol.1982,7(2):93-107.
  • 3[4]Doxon M F,Fulker MJ,Walker BE,et al.Serum transam inase levels after experinent paracetamol in duced hepatic necrosis.Gut,1975,116:800.
  • 4[5]Tredger JM,Sm ith HM,DavisM,et al.In vitro interactions of sulfur-containing compounds w ith the hepatic mixed-f unction oxidase system inm ice:effects on paracetamol activation and covalent binding.Toxicol A ppl Pharm acol,1981,59(1):111-124.
  • 5[6]Rosen GM,SingletaryWV,Rauckman EJ,et al.Acetam inophen hepatotoxicity.B iochem Pharm acol,1981,32:2053.
  • 6[8]Shayiq RM.Repeat exposure to increm ental doses of acetam inophen provides protection against acetam inophen-induced lethality in mice:an explanation for high acetam inophen dosage in humans without hepatic injuey.H epatology,1999,29(2):451-463.
  • 7[9]Lukasic GM,Klimaszy KD Alcohol-paracetamol syndrome:clinical issues.Przegl Lek,2002,59(4-5):381.

共引文献23

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部